Page 2 - Eric Ribner News Today

DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc. (Nasdaq: TRIB) (the “Company”) today announced that its New York based r...

DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a...

Conference Call Scheduled for Wednesday, January 31, 2024 at 8:30 AM ET...

DUBLIN, Ireland, Dec. 27, 2023 -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has...

Enrollment completed in placebo-controlled, randomized, dose-finding, multi-country, multi-center Phase II sepsis studyTopline Data Expected in late Q1 2024 Nes-Ziona, Israel, Dec. 20, 2023 ...

John Gillard Named Chief Executive OfficerDes Fitzgerald Named Interim Chief Financial OfficerDUBLIN, Ireland, Dec. 18, 2023 (GLOBE NEWSWIRE) --...

06.11.2023 - Company to host an investor conference call and webcast at 4:30pm EDTNEW YORK, Nov. 06, 2023 (GLOBE NEWSWIRE) - Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic technology company commercializing Mydcombi for mydriasis, preparing for regulatory ...

Nes-Ziona, Israel, Sept. 07, 2023 -- Enlivex Therapeutics Ltd. , a clinical-stage macrophage reprogramming immunotherapy company, today announced that company management will present a corporate...

NEW YORK, Aug. 09, 2023 -- Eyenovia, Inc. , an ophthalmic technology company commercializing Mydcombi™ 1%/2.5% for mydriasis and developing the Optejet® device for use both in connection with...

Eyenovia is stepping up the capabilities of its facilities and taking advantage of the thriving innovation culture and expertise in Reno, Nevada, ...